Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis

Interferon β-1a is a widely used immunomodulation treatment for multiple sclerosis. Liver function impairment is a common side effect and usually develops in the first 6 months after interferon use. Here, we describe 2 multiple sclerosis patients who developed delayed liver function impairment 5 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Ming-Feng, Yen, Su-Chen, Chun-Yen, Lin, Rong-Kuo, Lyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: July, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728605/
https://www.ncbi.nlm.nih.gov/pubmed/23904853
http://dx.doi.org/10.1159/000354042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728605/
https://www.ncbi.nlm.nih.gov/pubmed/23904853
http://dx.doi.org/10.1159/000354042

Ejemplares similares